Company Expects No Impact on
Operations
Negotiations with Key Secured Creditors
Progressing Toward a Balance Sheet Strengthening
Transaction
TREVOSE,
Pa., April 20, 2023 /PRNewswire/
-- Lannett Company, Inc. (LCI) ("Lannett" or "the Company")
today announced that it received a written notice from the New York
Stock Exchange ("NYSE") dated April 19,
2023, notifying the Company that the NYSE will commence
proceedings to delist the Company's common stock from the NYSE. The
NYSE reached this determination pursuant to Section 802.01B of the NYSE's Listed Company Manual
because the Company has fallen below the NYSE's continued listing
standard requiring listed companies to maintain an average global
market capitalization of at least $15,000,000 over a consecutive 30-trading day
period.
The NYSE suspended trading in the Company's common stock
immediately after market close on April 19,
2023. The Company's common stock will begin trading in the
over-the-counter market commencing on April
20, 2023. The common stock will retain the ticker symbol
(LCI).
The NYSE will apply to the Securities and Exchange Commission
(the "SEC") to delist the common stock upon completion of all
applicable procedures, including any appeal by the Company of the
NYSE's decision. The Company does not expect to appeal the
delisting.
The Company continues to engage in active discussions with key
secured creditors regarding a potential deleveraging transaction,
as previously announced. While the Company cannot provide any
assurance as to if or when it will consummate any such transactions
or the terms of any such transactions, the Company expects to be
able to reach an agreement with its key secured creditors in the
near term on such a transaction.
About Lannett Company, Inc.:
Lannett Company, founded
in 1942, develops, manufactures, packages, markets and distributes
generic pharmaceutical products for a wide range of medical
indications. For more information, visit the company's website at
www.lannett.com.
Forward Looking Statements:
This press release
contains forward-looking statements which are not historical facts
made pursuant to the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements are not promises or guarantees and investors are
cautioned that all forward-looking statements involve risks and
uncertainties, including but not limited to the impact of
competitive products and pricing, product demand and market
acceptance, new product development, acquisition-related
challenges, the regulatory environment, interest rate fluctuations,
reliance on key strategic alliances, availability of raw materials,
fluctuations in operating results, the impact of the delisting,
including under the indenture governing our convertible notes, the
impact of failure to pay interest when due on our debt, the ability
to implement a recapitalization, restructuring or similar
transaction and the terms of such a transaction, the impact if any
recapitalization, restructuring or similar transaction is
implemented under applicable bankruptcy laws, including Chapter 11
of the U.S. Bankruptcy Code, and other risks detailed from time to
time in our filings with the SEC. These statements are based on
management's current expectations and are naturally subject to
uncertainty and changes in circumstances. We caution you not to
place undue reliance upon any such forward-looking statements which
speak only as of the date made. Lannett is under no obligation to,
and expressly disclaims any such obligation to, update or alter its
forward-looking statements, whether as a result of new information,
future events or otherwise and other events or factors, many of
which are beyond our control, including those resulting from such
events, or the prospect of such events, such as public health
issues including health epidemics or pandemics, such as the
outbreak of the novel coronavirus, whether occurring in
the United States or elsewhere,
which could disrupt our operations, disrupt the operations of our
suppliers and business development and other strategic partners,
disrupt the global financial markets or result in political or
economic instability.
The information in this press release should be read in
conjunction with information in the Company's filings with the SEC,
including its most recent Annual Report on Form 10-K and Quarterly
Report on Form 10-Q.
Contact:
|
C Street Advisory
Group
|
|
lannett@thecstreet.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nyse-to-suspend-trading-immediately-in-lannett-company-inc-lci-and-commence-delisting-proceedings-301802729.html
SOURCE Lannett Company, Inc.